Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
Clinical Kidney Journal|May 7, 2021
Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns StudyEiichiro Kanda, Daniel Muenz, Brian Bieber, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 22, 2024
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient careMaria K Svensson, Toyoaki Murohara, Eva Lesén, et al.Kidney International|May 27, 2024
Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imagingYoshihisa Wada, Kengo Kidokoro, Megumi Kondo, et al.Diabetology & Metabolic Syndrome|March 7, 2018
Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)Hiroki Nakajima, Sadanori Okada, Takako Mohri, et al.Journal of Neurosurgery|January 14, 2023
Preoperative elevated eosinophils in peripheral blood for prediction of postoperative recurrence of chronic subdural hematomaMaoki Matsubara, Kenji Yagi, Yukari Minami, et al.Nephrology (Carlton, Vic.)|January 9, 2014
Decreased mobility after starting dialysis is an independent risk factor for short-term mortality after initiation of dialysisYohei Arai, Eiichiro Kanda, Hiroaki Kikuchi, et al.ESC Heart Failure|January 13, 2022
Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patientsMasahiro Eriguchi, Kazuhiko Tsuruya, Marcelo Lopes, et al.Scientific Reports|January 16, 2021
The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patientsEiichiro Kanda, Marcelo Barreto Lopes, Kazuhiko Tsuruya, et al.Clinical Kidney Journal|May 3, 2024
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort studyAnjay Rastogi, Charles V Pollack, Ignacio José Sánchez Lázaro, et al.Nephron|October 22, 2018
Dialysate Calcium Concentration below 3.0 mEq/L Is Not Associated with Improved Outcomes in the Japanese Dialysis Outcomes and Practice Patterns StudyKunitoshi Iseki, Lisa L Henn, Takanobu Nomura, et al.Pageof 15